Striatal allografts in patients with Huntingtons disease: impact of diminished astrocytes and vascularization on graft viability

Author： Cisbani Giulia

Publisher： Oxford University Press

ISSN： 1460-2156

Source： Brain, Vol.136, Iss.2, 2013-02, pp. : 433-443

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Striatal neural grafting improves cortical metabolism in Huntington’s disease patients

By Gaura Véronique

Brain, Vol. 127, Iss. 1, 2004-01 ,pp. : 65-72

Oxford University Press

Access to resources Recommend Favorite

Neuronal degeneration in striatal transplants and Huntingtons disease: potential mechanisms and clinical implications

By Cicchetti Francesca

Brain, Vol. 134, Iss. 3, 2011-03 ,pp. : 641-652

Oxford University Press

Access to resources Recommend Favorite

Progressive striatal and cortical dopamine receptor dysfunction in Huntington’s disease: a PET study

By Piccini P.

Brain, Vol. 126, Iss. 5, 2003-05 ,pp. : 1127-1135

Oxford University Press

Access to resources Recommend Favorite

Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntingtons disease

By Blzquez Cristina

Brain, Vol. 134, Iss. 1, 2011-01 ,pp. : 119-136

Oxford University Press

Access to resources Recommend Favorite

Oxidative Stress in Skin Fibroblasts Cultures of Patients with Huntington’s Disease

By Hoyo Pilar García-Redondo Alberto Bustos Fernando Molina José Sayed Youssef Alonso-Navarro Hortensia Caballero Luis Arenas Joaquín Jiménez-Jiménez Félix

Neurochemical Research, Vol. 31, Iss. 9, 2006-09 ,pp. : 1103-1109

Springer Publishing Company

Access to resources Recommend Favorite